Celgene to buy Juno for $9 billion

ReutersNewsPublished: January 22, 2018
Published: January 22, 2018

Celgene announced a $9 billion cash buyout of Juno Therapeutics as it moves to cement its position as a key player in a new range of cancer therapies. Aleksandra Michalska reports.

Be the first to suggest a tag

    Comments

    0 comments